Last edition
News about "Glenmark Pharma launches favipiravir drug for COVI"
Glenmark Pharma launches favipiravir drug for COVID-19 treatment
Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, has launched antiviral drug favipiravir (brand name FabiFlu) for the treatment of mild to moderate COVID-19 patients
Glenmark Pharma Launches Favipiravir Drug For COVI | 22/06/2020 | By Darshana | 376
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members